Category: Company News

CDX/MRD Coming Soon We are currently building something amazing for you. Stay tuned!

iCarbonX Pharmaceutical’s Antimicrobial Peptide Drug Candidate iCAMP016 Receives Clinical Trial Approval, Unleashing the Potential of Silicon-Based Chips + AI in Drug Discovery 2025-12-18 On December 17, 2025, iCAMP016 vaginal gel, an antimicrobial peptide Class I innovative drug…

iCarbonX Pharmaceutical Initiates Phase I Clinical Study of Antimicrobial Peptide Drug Candidate iCAMP016 On May 8, 2026, the initiation meeting for the Phase I clinical study of iCAMP016, an antimicrobial peptide drug candidate developed by iCarbonX Pharmaceutical,…